TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14602763

Group type: EXPERIMENTAL
Intervention: TRIAC (19.6 micro g/kg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: L-T4 (1.7 microg/kg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: TRIAC
Number of subjects: 36

Group type: COMPARATOR
Intervention: L-T4
Number of subjects: 36
Study: 10764851

Group type: EXPERIMENTAL
Intervention: Uncorrected visual acuity 0.50 (20/40) or worse in at least one eye
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Presenting visual acuity 0.50 (20/40) or worse in at least one eye
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Best visual acuity 0.50 (20/40) or worse in at least one eye
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Best visual acuity 0.50 or worse in both eyes
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Refractive error as a cause of reduced vision
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Amblyopia as a cause of reduced vision
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Other causes of reduced vision
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Unexplained causes of reduced vision
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Myopia (‐0.50 diopter or less) in 5-year-old children
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Myopia (‐0.50 diopter or less) in males by age 15
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Myopia (‐0.50 diopter or less) in females by age 15
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Hyperopia (2.00 diopters or greater) in males from age 5 to 15
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Hyperopia (2.00 diopters or greater) in females from age 5 to 15
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Risk of hyperopia in females compared to males
Number of subjects: 5303

Group type: EXPERIMENTAL
Intervention: Provision of proper spectacles
Number of subjects: 5303
Study: 8775350

Group type: EXPERIMENTAL
Intervention: Supervised physical training (PT) - 5 days/week for 10 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lifestyle education (LSE) - Weekly lifestyle discussions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both PT and LSE
Number of subjects: 12
Study: 1602037

Group type: EXPERIMENTAL
Intervention: Chlorhexidine strips
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Metronidazole strips
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Tetracycline strips
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Root planing
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Root planing followed by metronidazole strips
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 73
Study: 6463068

Group type: EXPERIMENTAL
Intervention: 600 mg oxiconazole (one vaginal tablet)
Number of subjects: 51

Group type: COMPARATOR
Intervention: 150 mg econazole (one ovule daily for 3 days)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 600 mg oxiconazole
Number of subjects: 51

Group type: COMPARATOR
Intervention: 150 mg econazole
Number of subjects: 51
Study: 31905348

Group type: EXPERIMENTAL
Intervention: GINA guidelines + FENO modification for ICS titration (group 2)
Number of subjects: 224

Group type: COMPARATOR
Intervention: GINA guidelines (group 1)
Number of subjects: 224
Study: 31571632

Group type: EXPERIMENTAL
Intervention: rTMS (1200 pulses in eight trains of 150 pulses each at 1Hz over the right dorsolateral prefrontal cortex)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (rTMS coil placed such that magnetic stimulation did not reach the cortex)
Number of subjects: 30
Study: 28546012

Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg.kg−1
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Clonidine 1 mcg.kg−1
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 mcg.kg−1
Number of subjects: 90
Study: 28768070

Group type: EXPERIMENTAL
Intervention: Comprehensive neurological and oculomotor exam; balance testing (Berg Balance Scale-BBS; Romberg Test-RT, Sharpened Romberg Test-SRT); olfactory function (Brief Smell Identification Test-BSIT)
Number of subjects: 71
Study: 24530273

Group type: EXPERIMENTAL
Intervention: Agomelatine 10 mg/day (n=133)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/day (n=138)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50 mg/day (n=137)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Agomelatine 10 mg/day
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/day
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50 mg/day
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg and 25-50 mg/day
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Agomelatine (all doses)
Number of subjects: 549
Study: 22397639

Group type: EXPERIMENTAL
Intervention: COACHES program
Number of subjects: 55

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 55

Group type: COMPARATOR
Intervention: Untreated mothers
Number of subjects: 55
Study: 20093327

Group type: EXPERIMENTAL
Intervention: Cycling intervention (30 sessions over 12 weeks)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 62
Study: 17522858

Group type: EXPERIMENTAL
Intervention: Clerad's GammaSup with a collimated CsI(Tl) scintillator
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Novelec's Modelo2 with a BGO scintillator
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Radioguided surgery using (18)F-FDG PET
Number of subjects: 7
Study: 15865948

Group type: EXPERIMENTAL
Intervention: Caregiver demand and control
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Decreasing control and increasing demand
Number of subjects: 138
Study: 15002600

Group type: EXPERIMENTAL
Intervention: Dietary treatment including high caloric intake, Calcium and Vitamin D supplementation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 19
Study: 9691101

Group type: EXPERIMENTAL
Intervention: Clodronate 1600 mg per day orally for two years
Number of subjects: 302

Group type: COMPARATOR
Intervention: Standard follow-up
Number of subjects: 302
Study: 7635030

Group type: EXPERIMENTAL
Intervention: Paclitaxel (Taxol‐Bristol‐Myers Squibb)
Number of subjects: 0
Study: 2751923

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 22
Study: 922295

Group type: EXPERIMENTAL
Intervention: Adhesive plastic drape
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Plastic ring protector
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard cloth towels (Control group A)
Number of subjects: 144
Study: 29149790

Group type: EXPERIMENTAL
Intervention: Physiotherapist-led physical exercise intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cohen-Mansfield Agitation Inventory
Number of subjects: 0
Study: 31455577

Group type: EXPERIMENTAL
Intervention: Positive note condition (90% of peers completed the task in less than 5 minutes)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Negative note condition (10% of peers completed the task in less than 5 minutes)
Number of subjects: 40
Study: 28695815

Group type: EXPERIMENTAL
Intervention: Forced-air warming system
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional warming care
Number of subjects: 62
Study: 24655152

Group type: EXPERIMENTAL
Intervention: Prioritizing attention on reaction time (RT) tasks
Number of subjects: 20
Study: 23223867

Group type: EXPERIMENTAL
Intervention: Prasugrel (with or without loading dose)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 95
Study: 21669954

Group type: EXPERIMENTAL
Intervention: dexamethasone 0.1 mg kg(‐1)
Number of subjects: 106

Group type: COMPARATOR
Intervention: dexamethasone 0.05 mg kg(‐1)
Number of subjects: 106

Group type: COMPARATOR
Intervention: saline
Number of subjects: 106
Study: 19382426

Group type: EXPERIMENTAL
Intervention: TPN supplemented with GLN dipeptide
Number of subjects: 40

Group type: COMPARATOR
Intervention: TPN without GLN dipeptide
Number of subjects: 40
Study: 16906286

Group type: EXPERIMENTAL
Intervention: Tomato paste (50 g daily for 10 weeks)
Number of subjects: 43
Study: 15335128

Group type: EXPERIMENTAL
Intervention: Integrated behavioral health care
Number of subjects: 127

Group type: COMPARATOR
Intervention: Enhanced referral care
Number of subjects: 127
Study: 11146347

Group type: EXPERIMENTAL
Intervention: Homeopathic Arnica CH5
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 9250266

Group type: EXPERIMENTAL
Intervention: sulphamethoxazole‐trimethoprim
Number of subjects: 0

Group type: COMPARATOR
Intervention: dapsone/pyrimethamine
Number of subjects: 0
Study: 8877185

Group type: EXPERIMENTAL
Intervention: Active device (pulsed electromagnetic stimulation)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 58
Study: 3522312

Group type: EXPERIMENTAL
Intervention: Tamoxifen (Tamofen, Leiras, or Nolvadex, ICI) 20 mg twice daily for 16 weeks
Number of subjects: 16
Study: 31296045

Group type: EXPERIMENTAL
Intervention: Nd:YAG 1064 nm short-pulse laser
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo sham laser
Number of subjects: 51
Study: 30100292

Group type: EXPERIMENTAL
Intervention: Integrated neurodynamic treatment (special care)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard dysarthria treatment (usual care)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 10
Study: 27163986

Group type: EXPERIMENTAL
Intervention: 3 mg macitentan
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: 10 mg macitentan
Number of subjects: 554

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 554
Study: 24582801

Group type: EXPERIMENTAL
Intervention: Thromboembolism (HR=1.95, <1 year after diagnosis; HR=7.83, 1-5 years after diagnosis)
Number of subjects: 11139

Group type: EXPERIMENTAL
Intervention: Hematologic complications (HR=1.84, <1 year after diagnosis; HR=7.11, 1-5 years after diagnosis)
Number of subjects: 11139

Group type: EXPERIMENTAL
Intervention: Infectious disease (HR=1.48, <1 year after diagnosis; HR=5.28, 1-5 years after diagnosis)
Number of subjects: 11139

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus and hypertension
Number of subjects: 11139
Study: 22414293

Group type: EXPERIMENTAL
Intervention: Phased multi-channel social norm marketing campaign addressing normative discrepancies (n = 25 intervention)
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Normal practice (n = 25 control)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Phased multi-channel social norm marketing campaign
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Normal practice
Number of subjects: 4000
Study: 19798465

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (EN) - elemental diet infusion during night-time and a low fat diet during daytime; 32 patients in the EN group.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Non-nutritional therapy (non-EN) - no nutritional therapy or food restriction; 24 patients in the non-EN group.
Number of subjects: 56
Study: 17622759

Group type: EXPERIMENTAL
Intervention: 25 mg sarpogrelate, orally, three times daily for 7 days
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 50 mg sarpogrelate, orally, three times daily for 7 days
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 100 mg sarpogrelate, orally, three times daily for 7 days
Number of subjects: 47
Study: 15598456

Group type: EXPERIMENTAL
Intervention: ACL deficient knee during terminal swing phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kinematic changes during swing phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnitude of the flexion moment during weight acceptance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptations to muscle firing patterns during walking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Altered rotational position during walking
Number of subjects: 0
Study: 12177804

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg (n=12)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Anastrozole 10 mg (n=11)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg or 10 mg)
Number of subjects: 23
Study: 10205205

Group type: EXPERIMENTAL
Intervention: Prucalopride 0.5 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prucalopride 4 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prucalopride (0.5, 2, and 4 mg doses)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 8548946

Group type: EXPERIMENTAL
Intervention: Goserelin plus 17 beta‐oestradiol and medroxyprogesterone acetate (Group 2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Goserelin alone (Group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 50
Study: 2634113

Group type: EXPERIMENTAL
Intervention: Incentive coupon combined with a prompt and information packet (47 subjects)
Number of subjects: 96

Group type: COMPARATOR
Intervention: No coupon (control group, 49 subjects)
Number of subjects: 96
Study: 329939

Group type: EXPERIMENTAL
Intervention: Layered monofilament nylon
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Mass polyglycolic acid
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Steel sutures
Number of subjects: 357
Study: 31963700

Group type: EXPERIMENTAL
Intervention: Group green exercise (running in a group of 4-5 participants)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lone green exercise (running alone)
Number of subjects: 40
Study: 30102872

Group type: EXPERIMENTAL
Intervention: Minimalist shoes
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional shoes
Number of subjects: 50
Study: 27804205

Group type: EXPERIMENTAL
Intervention: Two mini dental implants with Equator attachments
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Four mini dental implants with Equator attachments
Number of subjects: 60

Group type: COMPARATOR
Intervention: Two conventional dental implants with ball attachments
Number of subjects: 60
Study: 25581916

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 23972276

Group type: EXPERIMENTAL
Intervention: Health system navigator intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 21353663

Group type: EXPERIMENTAL
Intervention: Attention training to threat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 0
Study: 19474134

Group type: EXPERIMENTAL
Intervention: Hydrolyzed casein (CASH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intact casein (CAS)
Number of subjects: 10
Study: 16952777

Group type: EXPERIMENTAL
Intervention: Listening to music (n=89)
Number of subjects: 170

Group type: COMPARATOR
Intervention: No music (n=81)
Number of subjects: 170
Study: 14759242

Group type: EXPERIMENTAL
Intervention: Ampicillin + sulbactam (n = 37)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Clindamycin (n = 33) +/- cephalosporin
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 95
Study: 11770191

Group type: EXPERIMENTAL
Intervention: Estradiol + Trimegestone 0.5 mg
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Estradiol + Trimegestone 0.25 mg
Number of subjects: 487

Group type: COMPARATOR
Intervention: E2 + NETA
Number of subjects: 487
Study: 9783756

Group type: EXPERIMENTAL
Intervention: Prednisolone 7.5 mg daily
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 7888690

Group type: EXPERIMENTAL
Intervention: Diet containing 5% of total calories as refined sugar (group A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual 'sucrose-free' diet (group B)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Correlation of individual change in HbA1c with individual change in sucrose intake (group A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dietary assessment at baseline and follow-up
Number of subjects: 24
Study: 3062529

Group type: EXPERIMENTAL
Intervention: Levobunolol 0.25%
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Levobunolol 0.5%
Number of subjects: 85

Group type: COMPARATOR
Intervention: Betaxolol 0.5%
Number of subjects: 85
Study: 29381374

Group type: EXPERIMENTAL
Intervention: Hyperglycemia (130 mg/dl)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normoglycemia (95 mg/dl)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Insulin and leptin levels
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ghrelin levels
Number of subjects: 20
Study: 28277490

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 500 U kg‐1 per dose in 2 ml saline intravenously, given on alternate days for a total of five doses
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (placebo group), 2 ml given similarly for a total of five doses
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (placebo group)
Number of subjects: 100
Study: 26590242

Group type: EXPERIMENTAL
Intervention: Low dose motivational interviewing (4 calls)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose motivational interviewing (10 calls)
Number of subjects: 0
Study: 24899321

Group type: EXPERIMENTAL
Intervention: 2ml (10 mg) hyperbaric bupivacaine 0.5% plus 25 mg preservative free ketamine
Number of subjects: 100

Group type: COMPARATOR
Intervention: 2ml (10mg) hyperbaric bupivacaine 0.5% plus 25μg fentanyl
Number of subjects: 100
Study: 20092961

Group type: EXPERIMENTAL
Intervention: Bcl-2 positive tumors, 74 Gy
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Bcl-2 negative tumors, 74 Gy
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Bcl-2 expression
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: p53 expression
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: MDM2 expression
Number of subjects: 308
Study: 19127912

Group type: EXPERIMENTAL
Intervention: Acupuncture at 'cervical three points' combined with cake-separated moxibustion
Number of subjects: 91

Group type: COMPARATOR
Intervention: Routine acupuncture at Jiaji (EX-B 2)
Number of subjects: 91
Study: 17038305

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14521760

Group type: EXPERIMENTAL
Intervention: Captopril (group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine treatment (group B)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Healthy volunteers (group C)
Number of subjects: 72
Study: 11194611

Group type: EXPERIMENTAL
Intervention: Tissue expander implantation
Number of subjects: 0
Study: 8864680

Group type: EXPERIMENTAL
Intervention: Omeprazole 20mg once daily for 5 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Omeprazole 40mg once daily for 5 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Omeprazole 80mg once daily for 5 days
Number of subjects: 18
Study: 1642520

Group type: EXPERIMENTAL
Intervention: Deep diaphragmatic breathing training
Number of subjects: 67

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Physical exercise training
Number of subjects: 67
Study: 6381337

Group type: EXPERIMENTAL
Intervention: human fibroblast interferon (beta 1-type)
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 31574029

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical Minoxidil
Number of subjects: 20
Study: 30964365

Group type: EXPERIMENTAL
Intervention: Reslizumab add-on therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care alone (high-dose ICS/LABA)
Number of subjects: 0
Study: 28776094

Group type: EXPERIMENTAL
Intervention: mindfulness based self-help programme (iMBI)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: music based self-help programme
Number of subjects: 283

Group type: COMPARATOR
Intervention: waiting list control group
Number of subjects: 283
Study: 26705327

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields (PEMF) therapy for 12 hours daily for 1 month
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 24577972

Group type: EXPERIMENTAL
Intervention: 12-month preventive intervention group
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard care control group
Number of subjects: 170
Study: 22658168

Group type: EXPERIMENTAL
Intervention: Nerve stimulation guided obturator nerve block with 15 mL of lidocaine HCl 2%
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Nerve stimulation guided obturator nerve block with 20 mL of saline
Number of subjects: 112

Group type: COMPARATOR
Intervention: Blind obturator nerve block based on anatomic landmarks
Number of subjects: 112
Study: 20304563

Group type: EXPERIMENTAL
Intervention: Prenatal glucocorticoids and estrogen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregnancy
Number of subjects: 0
Study: 17388849

Group type: EXPERIMENTAL
Intervention: Usual care plus cognitive nursing intervention (UC + CNI)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 65
Study: 15766817

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Shear stress (SS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Baseline WT
Number of subjects: 10
Study: 16475175

Group type: EXPERIMENTAL
Intervention: Volumatic Soft (VS)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Volumatic (V)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Preference score for Volumatic (V)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Preference score for Volumatic Soft (VS)
Number of subjects: 44
Study: 10827335

Group type: EXPERIMENTAL
Intervention: Tactylon condoms
Number of subjects: 443

Group type: COMPARATOR
Intervention: Latex condom
Number of subjects: 443
Study: 8655825

Group type: EXPERIMENTAL
Intervention: Retropubic urethrocystopexy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pubococcygeal repair
Number of subjects: 45
Study: 1519391

Group type: EXPERIMENTAL
Intervention: Mezlocillin/Metronidazole (group A)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Amoxicillin/Clavulanic acid (group B)
Number of subjects: 111